IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMIR GAMAL ISHAK

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1548257488
CMS profile
341703
Location
PORTLAND, IN

General Payments · PY2018–2024

$5,965.56

  • Reported across 377 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,149.96

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry IN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,054.96 51
Education $95.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alkermes, Inc. $262.63 11
Teva Pharmaceuticals USA, Inc. $248.48 11
Otsuka America Pharmaceutical, Inc. $246.22 11
ITI, Inc. $141.81 8
E.R. Squibb & Sons, L.L.C. $72.75 3
Neurocrine BioSciences, Inc. $57.92 3
Lundbeck LLC $53.29 2
BioXcel Therapeutics, Inc. $26.78 1
Indivior Inc. $26.14 1
ABBVIE INC. $13.94 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $229.99 17
PY2019 $479.44 54
PY2020 $497.07 25
PY2021 $1,113.96 83
PY2022 $1,467.28 92
PY2023 $1,027.86 54
PY2024 $1,149.96 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.94 01/27/2024 Food and Beverage Undisputed 01/23/2026 1103971873 CMS
Alkermes, Inc. $28.09 01/29/2024 Food and Beverage Undisputed 01/23/2026 1120521817 CMS
Alkermes, Inc. $22.70 02/26/2024 Food and Beverage Undisputed 01/23/2026 1120521819 CMS
Alkermes, Inc. $19.20 03/25/2024 Food and Beverage Undisputed 01/23/2026 1120521821 CMS
Alkermes, Inc. $26.81 04/22/2024 Food and Beverage Undisputed 01/23/2026 1120521823 CMS
Alkermes, Inc. $25.54 05/20/2024 Food and Beverage Undisputed 01/23/2026 1120521825 CMS
Alkermes, Inc. $19.85 06/24/2024 Food and Beverage Undisputed 01/23/2026 1120521827 CMS
Alkermes, Inc. $28.22 07/22/2024 Food and Beverage Undisputed 01/23/2026 1120521829 CMS
Alkermes, Inc. $17.90 08/12/2024 Food and Beverage Undisputed 01/23/2026 1120521831 CMS
Alkermes, Inc. $26.11 10/18/2024 Food and Beverage Undisputed 01/23/2026 1120521833 CMS
Alkermes, Inc. $25.62 11/04/2024 Food and Beverage Undisputed 01/23/2026 1120521835 CMS
Alkermes, Inc. $22.59 11/18/2024 Food and Beverage Undisputed 01/23/2026 1120521837 CMS
BioXcel Therapeutics, Inc. $26.78 07/20/2024 Food and Beverage Undisputed 01/23/2026 1150028894 CMS
E.R. Squibb & Sons, L.L.C. $24.50 11/06/2024 Food and Beverage Undisputed 01/23/2026 1101679509 CMS
E.R. Squibb & Sons, L.L.C. $24.99 12/09/2024 Food and Beverage Undisputed 01/23/2026 1101679512 CMS
E.R. Squibb & Sons, L.L.C. $23.26 12/18/2024 Food and Beverage Undisputed 01/23/2026 1101679516 CMS
Indivior Inc. $26.14 05/13/2024 Food and Beverage Undisputed 01/23/2026 1144530294 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.28 01/11/2024 Food and Beverage Undisputed 01/23/2026 1143247224 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.63 01/29/2024 Food and Beverage Undisputed 01/23/2026 1143247227 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.81 03/20/2024 Food and Beverage Undisputed 01/23/2026 1143247231 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.52 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143247235 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.25 05/29/2024 Food and Beverage Undisputed 01/23/2026 1143247238 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.47 06/17/2024 Food and Beverage Undisputed 01/23/2026 1143247242 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.03 07/24/2024 Food and Beverage Undisputed 01/23/2026 1143247246 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.82 08/02/2024 Food and Beverage Undisputed 01/23/2026 1143247249 CMS
Lundbeck LLC $24.42 03/29/2024 Food and Beverage Undisputed 01/23/2026 1145927882 CMS
Lundbeck LLC $28.87 07/17/2024 Food and Beverage Undisputed 01/23/2026 1145927884 CMS
Neurocrine Biosciences, Inc. $14.92 04/24/2024 Food and Beverage Undisputed 01/23/2026 1150875362 CMS
Neurocrine Biosciences, Inc. $24.34 10/01/2024 Food and Beverage Undisputed 01/23/2026 1150841978 CMS
Neurocrine Biosciences, Inc. $18.66 12/15/2024 Food and Beverage Undisputed 01/23/2026 1150863389 CMS
Otsuka America Pharmaceutical, Inc. $25.11 01/17/2024 Food and Beverage Undisputed 01/23/2026 1118912691 CMS
Otsuka America Pharmaceutical, Inc. $27.92 02/14/2024 Food and Beverage Undisputed 01/23/2026 1118912693 CMS
Otsuka America Pharmaceutical, Inc. $20.11 04/10/2024 Food and Beverage Undisputed 01/23/2026 1118912695 CMS
Otsuka America Pharmaceutical, Inc. $28.42 05/17/2024 Food and Beverage Undisputed 01/23/2026 1118912697 CMS
Otsuka America Pharmaceutical, Inc. $29.98 06/05/2024 Food and Beverage Undisputed 01/23/2026 1118912699 CMS
Otsuka America Pharmaceutical, Inc. $29.09 09/11/2024 Food and Beverage Undisputed 01/23/2026 1118912701 CMS
Otsuka America Pharmaceutical, Inc. $17.95 09/25/2024 Food and Beverage Undisputed 01/23/2026 1118912703 CMS
Otsuka America Pharmaceutical, Inc. $0.85 09/25/2024 Food and Beverage Undisputed 01/23/2026 1118912705 CMS
Otsuka America Pharmaceutical, Inc. $16.27 10/16/2024 Food and Beverage Undisputed 01/23/2026 1118912707 CMS
Otsuka America Pharmaceutical, Inc. $21.79 11/13/2024 Food and Beverage Undisputed 01/23/2026 1118912709 CMS
Otsuka America Pharmaceutical, Inc. $28.73 11/20/2024 Food and Beverage Undisputed 01/23/2026 1118912711 CMS
Teva Pharmaceuticals USA, Inc. $16.27 03/23/2024 Food and Beverage Undisputed 01/23/2026 1151578264 CMS
Teva Pharmaceuticals USA, Inc. $17.32 04/22/2024 Food and Beverage Undisputed 01/23/2026 1151578284 CMS
Teva Pharmaceuticals USA, Inc. $18.11 05/21/2024 Food and Beverage Undisputed 01/23/2026 1151578288 CMS
Teva Pharmaceuticals USA, Inc. $95.00 05/21/2024 Education Undisputed 01/23/2026 1151578424 CMS
Teva Pharmaceuticals USA, Inc. $6.14 06/19/2024 Food and Beverage Undisputed 01/23/2026 1151578364 CMS
Teva Pharmaceuticals USA, Inc. $18.14 06/25/2024 Food and Beverage Undisputed 01/23/2026 1151578368 CMS
Teva Pharmaceuticals USA, Inc. $18.52 07/11/2024 Food and Beverage Undisputed 01/23/2026 1151578372 CMS
Teva Pharmaceuticals USA, Inc. $6.67 07/18/2024 Food and Beverage Undisputed 01/23/2026 1151578376 CMS
Teva Pharmaceuticals USA, Inc. $14.03 08/07/2024 Food and Beverage Undisputed 01/23/2026 1151578420 CMS
Teva Pharmaceuticals USA, Inc. $21.89 09/17/2024 Food and Beverage Undisputed 01/23/2026 1151578440 CMS
Teva Pharmaceuticals USA, Inc. $16.39 10/24/2024 Food and Beverage Undisputed 01/23/2026 1151578468 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.